Chiron Recombinant Proteins is carrying the biomanufacturing legacy of Grifols with a state-of-the-art biological GMP manufacturing facility in the San Francisco Bay Area. The company was launched in 2021 for companies seeking innovation, capability, and flexibility. Chiron Recombinant Proteins is composed of highly experienced staff. Their CMF pilot plant and analytical laboratories are well positioned to provide long-term, high-quality commercial manufacturing of recombinant biologic drug substances from the research through commercial stages for partners all over the world.